Mepsevii
Chemical Name | vestronidase alfa |
Dosage Form | Injection (intravenous; 10 mg/5 mL) |
Drug Class | Enzymes |
System | Nervous, Digestive, Musculoskeletal, Endocrine |
Company | Ultragenyx Pharm Inc |
Approval Year | 2017 |
Indication
- To treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome.